Valuation: Alembic Pharmaceuticals Limited

Market Cap 161B 1.68B 1.48B 1.38B 1.27B 2.37B 2.41B 16.33B 6.39B 79.82B 6.32B 6.19B 276B P/E 2027 *
21.6x
P/E 2028 * 16.9x
Enterprise Value 170B 1.78B 1.57B 1.46B 1.34B 2.51B 2.56B 17.29B 6.77B 84.5B 6.7B 6.55B 292B EV / Sales 2027 *
2.07x
EV / Sales 2028 * 1.8x
Free-Float
29.3%
Yield 2027 *
1.57%
Yield 2028 * 1.86%
1 day-1.30%
1 week-0.49%
Current month-1.77%
1 month+2.74%
3 months+6.19%
6 months+5.88%
Current year-4.49%
1 week 787.4
Extreme 787.4
828
1 month 784.15
Extreme 784.15
855.4
Current year 635.8
Extreme 635.8
855.4
1 year 635.8
Extreme 635.8
1,026.2
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 2025-07-06
Chief Tech/Sci/R&D Officer - 2023-06-30
Chief Operating Officer - 2025-07-20
Director TitleAgeSince
Chairman 78 2012-06-07
Director/Board Member 50 2006-12-31
Director/Board Member 66 2003-01-17
Date Insider Type Main position Quantity % Market Cap.
3/28/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
3/24/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
3/21/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-1.36%-0.49%-20.23%+4.36% 1.68B
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
+0.14%+10.71%+41.81%+35.99% 359B
+0.36%+4.72%+38.58%+44.13% 303B
+1.29%+3.24%+17.53%+17.24% 267B
-0.16%+4.57%-3.69%-38.82% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +1.31%+4.39%+27.44%+49.76% 373.28B
Weighted average by Cap. +1.56%+5.14%+40.99%+79.90%

Financials

2027 *2028 *
Net sales 82.16B 860M 755M 703M 646M 1.21B 1.23B 8.34B 3.26B 40.74B 3.23B 3.16B 141B 90.29B 945M 829M 772M 710M 1.33B 1.35B 9.16B 3.59B 44.78B 3.55B 3.47B 155B
Net income 7.51B 78.64M 69.01M 64.27M 59.11M 111M 113M 762M 298M 3.73B 295M 289M 12.87B 9.52B 99.62M 87.43M 81.42M 74.88M 140M 143M 966M 378M 4.72B 374M 366M 16.31B
Net Debt 9.43B 98.71M 86.63M 80.67M 74.2M 139M 141M 957M 375M 4.68B 371M 363M 16.16B 1.32B 13.77M 12.09M 11.26M 10.35M 19.41M 19.74M 134M 52.27M 653M 51.71M 50.59M 2.25B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
26-07-29 807.75 -1.36% 52,294
26-07-28 ₹818.85 +0.54% 74,793
26-07-27 ₹814.45 +2.11% 50,274
26-07-24 ₹797.60 -0.09% 36,166
26-07-23 ₹798.35 -1.71% 63,082
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
818.85INR
Average target price
918.20INR
Spread / Average Target
+12.13%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock